Dr. Hyeun Ah Kang is an Assistant Professor in the Health Outcomes Division at The University of Texas College of Pharmacy. Her current research activities focus on evaluating health care resource utilization, costs, and predictors of clinical and economic outcomes using large real-world databases. Her research interests include sickle cell disease, opioid use, and oncology.
Dr. Kang is a recipient of numerous merit awards including the 2021-2022 American Association of Colleges of Pharmacy (AACP) New Investigator Award, Best Student Poster Research Presentation at the 2018 and 2019 ISPOR Annual International Meetings, 2019 APhA Academy of Pharmaceutical Research and Science (APRS) Presentation Award, and Abstract Award Winner-Graduate Program at the UT Austin College of Pharmacy 15th Annual Louis C. Littlefield Celebrating Pharmacy Research Excellence Day (2019).
Her teaching focuses on Pharmacoeconomics, health care systems, research methods, and data analysis. She earned her Bachelor’s and Master’s degrees in Pharmacy in South Korea in 2009 and 2011, respectively, and worked as a researcher for the Health Insurance Review & Assessment services (HIRA) in South Korea. She received her M.Ed. degree in Quantitative Methods from the UT Austin College of Education and Ph.D. in Health Outcomes from the UT Austin College of Pharmacy in 2017 and 2019, respectively. She is the TxCORE Outstanding Graduate Student Award co-winner (2019) and was a faculty member at the University of Texas at El Paso School of Pharmacy from 2019 – 2021.
Ph.D., The University of Texas at Austin
M.Ed., The University of Texas at Austin
M.Pharm, Sookmyung Women’s University
B.Pharm, Sookmyung Women’s University
Google Scholar: https://scholar.google.com/citations?hl=en&user=7396VV8AAAAJ
Selected Recent Publications
*Denotes student(s)/trainee(s) at the time of the study.
CORE Research Area: Patient-Centered Outcomes Research
Kang HA and Barner JC. The relationship between out-of-pocket healthcare expenditures and insurance status among individuals with chronic obstructive pulmonary disease. Journal of Pharmaceutical Health Services Research. 2017;8(2):107-113. Doi: 10.1111/jphs.12170.
CORE Research Area: Healthcare Systems Research
Kang HA, Lee S, Park C, and Kim DS. Prevalence and predictors of non-steroidal anti-inflammatory drug/analgesic therapeutic duplication in the South Korean ambulatory care setting. European Journal of Clinical Pharmacology. 2016;72(1):109-116. doi: 10.1007/s00228-015-1958-0.
Kim DS, Je NK, Kim GJ, Kang HA, Kim YJ, and Lee S. Therapeutic duplicate prescribing in Korean ambulatory care settings using the National Health Insurance claim data. International Journal of Clinical Pharmacy. 2015;37(1):76-85. doi: 10.1007/s11096-014-0042-7.
Kang HA, Kim HS, Oh CH, and Shin HT. Evaluation of the sensitivity and specificity of national DUR Program: Focused on drug-drug interaction. Journal of Korean Academy of Managed Care Pharmacy. 2011, 3(1):16-22.
CORE Research Area: Health Economics and Outcomes Research
Kang HA, Barner JC. The association between hydroxyurea adherence and opioid utilization among Texas Medicaid enrollees with sickle cell disease. Journal of Managed Care & Specialty Pharmacy. 2020;26(11):1412-1422. doi: 10.18553/jmcp.2020.26.11.1412.
Kang HA, Barner JC, Richards K, Bhor M, Paulose J, Kutlar A. Association between vaso-occlusive crises and opioid prescriptions among patients with sickle cell disease: A retrospective claims-based study. Journal of Health Economics and Outcomes Research. 2020; 7(1):94-101. doi: 10.36469/jheor.2020.13348.
Barner JC, Petrilla AA, Kang HA, Shen X, Alshehri AM, Sullivan E, Troeger KA, Richards KM, and Blackwell SC. Fetal fibronectin testing and pregnancy outcomes among Texas Medicaid patients at risk for preterm birth. The American Journal of Managed Care. 2017;23(19 Suppl):S363-S370.
PGS 390U Advanced Research Methods (Topic: Propensity Scoring)